Stock daily read

What happened with ARAI today?

Why it moved
Explains possible causes using the day’s news and filings
Moving with the market?
Uses market moves and trading volume to assess what drove the change
What to watch next
The next thing that could change the call, and what to look for

No read yet

Uses news and trading volume to explain the day’s move and how it relates to the market.

Investment outlook

ARAI in three months: buy, wait or sell?

Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.

In the report
  • Buy / Wait / Sell rating
  • 3-month target price
  • Bear · Base · Bull
  • vs. the market

Company

Company overview

Arrive AI Inc. is developing Arrive Points: smart lockers and small transfer facilities where drones, robots, delivery providers and people can securely leave and collect goods without arriving at the same time. It provides the exchange infrastructure, not the drones that deliver to it. The company plans to target healthcare operations first, including hospitals, laboratories and pharmacies.

Commercial operations began in 2025 and revenue remains limited. Most revenue to date has come from design and consulting services, with Hancock Health supplying almost all revenue. Customers also pay installation fees and subscriptions for Arrive Points. Consulting and installation are generally one-off projects; subscriptions provide recurring payments. The company intends to expand subscriptions into a service covering hardware, software, installation and ongoing support. Its ALM Marketplace, which would manage demand for delivery slots and space, and AI Services using network data are planned revenue sources, not established businesses.

Expansion depends on customers adopting and renewing the service, additional funding, and delivery partners obtaining the approvals needed to operate, including access to airspace and wireless spectrum. Arrive AI also relies heavily on technology licensed exclusively from its CEO, Daniel O’Toole. A material breach of that license could cost it exclusivity, and termination could effectively end some or all operations.

Read allShow less
Source: SEC filing

Red flags

Know what’s buried in ARAI’s filings before you buy

The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.

Sorted into
  • Happening now
  • Could go wrong
  • Built in

Moat

ARAI says it has a moat. Does it hold up?

Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.

Each edge rated
  • Strong
  • Moderate
  • Limited
  • Unproven

Related companies

Arrive AI currently depends heavily on Hancock Health and needs more customers to adopt its access points for autonomous deliveries, where it names Matternet and Valqari as direct competitors.

Agenda

in 23 daysThu, Nov 12

  1. Time to be announced
    Major

    Arrive AI Inc. earningsThis company

    Arrive AI’s report will show whether revenue is shifting from project work for a concentrated customer base toward repeat Arrive Point subscriptions.